Study #PA16-0003
A prospective laboratory study of tumor cells and biomarkers in the cerebrospinal fluid of patients with suspected or confirmed leptomeningeal disease.
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
Prospective LMD CSF Lab Study
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Barbara O'Brien
Department:
Neuro-Oncology
For general questions about clinical trials:
1-855-996-1481
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.